. Resumos Científicos

Nivolumab in patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) metastatic colorectal cancer (mCRC): Long-term survival according to prior line of treatment from CheckMate-142.
Por: Heberton Medeiros
Os resultados de sobrevida de longo prazo do estudo Chekmate-142 foram apresentados no congresso americano de tumores do trato gastrintestinal ocorrido em San Francisco – EUA entre os dias 18 e 20 de janeiro de 2018, apresentado por Michael J Overman, MD da universidade do Texas MD Anderson Cancer Center. Leia Mais
PROSPER trial: Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Por: Carolina Matias
PROSPER trial: Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer Leia Mais
Want create site? Find Free WordPress Themes and plugins.
Did you find apk for android? You can find new Free Android Games and apps.